Mattias Öberg
Om mig
Mitt huvudsakliga forskningsområde är hälsorisker med kemikalier. Det är ett tvärvetenskaplig forskningsområde och jag arbetar nära ett stort nätverk av svenska och internationella forskare, myndigheter och organisationer. Jag är svensk representant i den nordiska expertgruppen för riskbedömningar av kemikalier i arbetsmiljön, ordförande i den nationella kommittén för European Registered Toxicologists och ledamot i Eurotox Executive Committee. Jag är dessutom expertkoordinator inom kemiska och toxikologiska händelser på KI:s Centrum för hälsokriser.
Jag är djupt engagerad i att nå ut med och kommunicera kunskap om hälsorisker med kemikalier. Jag har varit engagerad som sakkunnig och expertvittne i PFAS-målet i Kallinge. Dessutom medverkade jag i podcastdokumentär Mörkt Vatten, som handlar om händelserna i Kallinge. Mörkt Vatten vann Radioakademins pris Guldörat i kategorin Bästa Avslöjande 2023.
Tillsammans med epidemiologen Emma Frans har jag producerat och medverkat i podcastserien Riskzonen. Varje avsnitt av podden ger ett vetenskapligt perspektiv på händelser som skakat världen och påverkat hur vi ser på risker. Fjärde säsongen av Riskzonen kom ut våren, sommaren och hösten 2023 och producerades i samarbete med Centrum för hälsokriser.
Katastroftoxikologi och kriget i Ukraina:
I samband med kriget i Ukraina finns risk för utsläpp av farliga kemikalier. Det handlar till exempel om utsläpp som sker i samband med skador på kemiska anläggningar och transporter av farligt gods. Men det kan också handla om kemiska vapen och högtoxiska ämnen som i närtid använts för att förgifta politiska motståndare i flera länder. Jag har i min forskning särskilt studerat riskerna med luftburna ämnen, effekterna på känsliga grupper som astmatiker, och hur man kan beräkna sambanden mellan dos och effekt. Jag har även medverkat i utformningen av MSB:s beslutsstöd när det gäller kemiska händelser och undervisar masterstudenter i katastroftoxikologi.
Forskningsbeskrivning
Aktuella projekt som projektledare:
- Experimental design aligned with dose-response modelling as a means for 3R in toxicity testing (Finansiering: Vetenskapsrådet)
- Bayesian dose-response modelling aligned with experimental design as means to improve chemical risk assessment (Finansiering: Formas)
- Risk, Fara, Oro, Skada - ett kommunikationsprojekt (Finansiering: Formas)
- Kemiska olyckor i arbetslivet – systematisk analys av Giftinformationscentralens arbetsmiljörelaterade data (Finansiering: AFA Försäkring)
Övriga projekt där jag deltar: - PERFORCE3, a Innovative Training Network about perfluorinated chemicals. (PI: Ian Cousins; Finansiering: European Union’s Horizon 2020)
- Phthalates in female reproduction –impact of mixture composition on hazard characterization (PI: Pauliina Damdimopoulou, Karolinska
Institutet, Finansiering: Formas) - New animal-free methods to meet the need for safe chemicals (PI: Elin Törnqvist, Karolinska Institutet, Finansiering: Formas)
Undervisning
Jag har erfarenhet av att arbeta med undervisning på många nivåer, både som kursledare, föreläsare och handledare av studenter på masternivå, doktorander och post docs.
Jag är/har varit handledare för fyra egna doktorander:- Mia Johansson (2016) - Asthmatics as a susceptible population in health risk assessment of airborne chemicals
- Joakim Ringblom (2016) - Worth weighting for - Studies on benchmark dose analysis in relation to animal ethics in toxicity testing
- Antero Silva (planerad disputation 2022) - Benchmark dose modelling for hazard and risk characterization of chemicals
- Lars Brunken (planerad disputation 2024) - Dose-response assessment of PFAS mixtures in relation to biomarkers of effects relevant for cardiovascular disease in humans.
Artiklar
- Journal article: TOXICOLOGY LETTERS. 2025;411:s322-s322aBrunken L; Silva AV; Sadrabadi F; Oberg M
- Article: TOXICOLOGICAL SCIENCES. 2025;206(1):30-45Silva AV; Tarvainen I; Oberg M; Laws M; Hannon P; Flaws J; Damdimopoulou P
- Article: FRONTIERS IN TOXICOLOGY. 2025;7:1525089Brunken L; Silva AV; Oberg M
- Journal article: TOXICOLOGY LETTERS. 2024;399:s193Silva AV; Flaws J; Laws M; Oberg M; Damdimopoulou P
- Article: REPRODUCTIVE TOXICOLOGY. 2024;128:108660Visser N; Silva AV; Tarvainen I; Damdimopoulos A; Davey E; Roos K; Bjorvang RD; Kallak TK; Lager S; Lavogina D; Laws M; Piltonen T; Salumets A; Flaws JA; Oberg M; Velthut-Meikas A; Damdimopoulou P; Olovsson M
- Article: ENVIRONMENT INTERNATIONAL. 2024;190:108942Galvao MFDO; Scaramboni C; Endirlik BU; Silva AV; Oberg M; Pozza SA; Watanabe T; Rodrigues PCDO; Vasconcellos PDC; Sadiktsis I; Dreij K
- Article: TOXICOLOGY. 2024;506:153862Kashobwe L; Sadrabadi F; Brunken L; Coelho ACMF; Sandanger TM; Braeuning A; Buhrke T; Oberg M; Hamers T; Leonards PEG
- Article: REPRODUCTIVE TOXICOLOGY. 2023;119:108393Tarvainen I; Soto DA; Laws MJ; Bjorvang RD; Damdimopoulos A; Roos K; Li T; Kramer S; Li Z; Lavogina D; Visser N; Kallak TK; Lager S; Gidlof S; Edlund E; Papaikonomou K; Oberg M; Olovsson M; Salumets A; Velthut-Meikas A; Flaws JA; Damdimopoulou P
- Article: FOOD AND CHEMICAL TOXICOLOGY. 2022;161:112842Norgren K; Tuck A; Silva AV; Burkhardt P; Oberg M; Kos VM
- Article: SCIENCE. 2022;375(6582):eabe8244Caporale N; Leemans M; Birgersson L; Germain P-L; Cheroni C; Borbely G; Engdahl E; Lindh C; Bressan RB; Cavallo F; Chorev NE; D'Agostino GA; Pollard SM; Rigoli MT; Tenderini E; Tobon AL; Trattaro S; Troglio F; Zanella M; Bergman A; Damdimopoulou P; Jonsson M; Kiess W; Kitraki E; Kiviranta H; Nanberg E; Oberg M; Rantakokko P; Ruden C; Soder O; Bornehag C-G; Demeneix B; Fini J-B; Gennings C; Ruegg J; Sturve J; Testa G
- Article: REPRODUCTIVE TOXICOLOGY. 2022;107:123-139Silva AV; Chu I; Feeley M; Bergman A; Hakansson H; Oberg M
- Article: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2021;433:115732Silva AV; Ringblom J; Moldeus P; Tornqvist E; Oberg M
- Article: ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION. 2021;38(2):198-214Silva AV; Norinder U; Liiv E; Platzack B; Oberg M; Tornqvist E
- Article: INTERNATIONAL JOURNAL OF OCCUPATIONAL SAFETY AND ERGONOMICS. 2020;26(1):140-148Schenk L; Feychting K; Annas A; Oberg M
- Article: ENVIRONMENT INTERNATIONAL. 2018;120:535-543Gennings C; Shu H; Ruden C; Oberg M; Lindh C; Kiviranta H; Bornehag C-G
- Journal article: ISEE CONFERENCE ABSTRACTS. 2018;2018(1)Gennings C; Shu H; Ruden C; Oberg M; Lindh C; Kiviranti H; Bornehag C-G
- Article: JOURNAL OF CHEMICAL EDUCATION. 2018;95(7):1132-1139Schenk L; Taher IA; Oberg M
- Article: RISK ANALYSIS. 2018;38(6):1143-1153Ringblom J; Kalantari F; Johanson G; Oberg M
- Article: ANNALS OF WORK EXPOSURES AND HEALTH. 2018;62(5):517-529Schenk L; Oberg M
- Article: SAFETY SCIENCE. 2018;104:269-275Schenk L; Feychting K; Annas A; Oberg M
- Article: RISK ANALYSIS. 2017;37(9):1716-1728Kalantari F; Ringblom J; Sand S; Oberg M
- Article: INHALATION TOXICOLOGY. 2017;29(2):82-91Johansson M; Gustafsson A; Johanson G; Oberg M
- Article: ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION. 2017;34(1):148-156Ringblom J; Toernqvist E; Hansson SO; Ruden C; Oberg M
- Article: JOURNAL OF APPLIED TOXICOLOGY. 2016;36(11):1379-1391Johansson MKV; Johanson G; Oberg M; Schenk L
- Article: ENVIRONMENTAL HEALTH PERSPECTIVES. 2016;124(5):A81-A83Lind L; Lind PM; Lejonklou MH; Dunder L; Bergman A; Guerrero-Bosagna C; Lampa E; Lee HK; Legler J; Nadal A; Pak YK; Phipps RP; Vandenberg LN; Zalko D; Agerstrand M; Oberg M; Blumberg B; Heindel JJ; Birnbaum LS
- Article: TOXICOLOGY IN VITRO. 2015;29(5):876-883Herlin M; Oberg M; Ringblom J; Joseph B; Korkalainen M; Viluksela M; Heimeier RA; Hakansson H
- Article: ENVIRONMENTAL HEALTH PERSPECTIVES. 2014;122(12):1321-1328van Wendel de Joode B; Maria Mora A; Cordoba L; Camilo Cano J; Quesada R; Faniband M; Wesseling C; Ruepert C; Oberg M; Eskenazi B; Mergler D; Lindh CH
- Journal article: ISEE CONFERENCE ABSTRACTS. 2014;2014(1)de Joode* BVW; Mora AM; Córdoba L; Cano C; Quesada R; Faniband M; Wesseling C; Ruepert C; Öberg M; Eskenazi B; Mergler D; Lindh C
- Article: PLOS ONE. 2014;9(7):e101638Tornqvist E; Annas A; Granath B; Jalkesten E; Cotgreave I; Oberg M
- Article: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2014;69(2):234-242Annys E; Billington R; Clayton R; Bremm K-D; Graziano M; McKelvie J; Ragan I; Schwarz M; van der Laan JW; Wood C; Oberg M; Wester P; Woodward KN
- Article: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2014;69(2):171-177Ringblom J; Johanson G; Oberg M
- Article: JOURNAL OF APPLIED TOXICOLOGY. 2012;32(10):843-849Sand S; Ringblom J; Hakansson H; Oberg M
- Article: ENVIRONMENTAL RESEARCH. 2012;117:17-26van Wendel de Joode B; Barraza D; Ruepert C; Maria Mora A; Cordoba L; Oberg M; Wesseling C; Mergler D; Lindh CH
- Article: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2012;63(3):461-470Johansson MKV; Johanson G; Oberg M
- Article: LANCET. 2011;377(9760):139-146Oberg M; Jaakkola MS; Woodward A; Peruga A; Pruess-Ustuen A
- Article: JOURNAL OF HAZARDOUS MATERIALS. 2010;184(1-3):439-447Oberg M; Palmen N; Johanson G
- Article: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2010;58(3):451-454Oberg M
- Article: CHEMOSPHERE. 2010;80(2):137-143Oberg M; Westerholm E; Fattore E; Stern N; Hanberg A; Haglund P; Wiberg K; Bergendorff A; Hakansson H
- Article: PUBLIC HEALTH REPORTS. 2010;125(3):478-487Boldo E; Medina S; Oberg M; Puklova V; Mekel O; Patja K; Dalbokova D; Krzyzanowski M; Posada M
- Article: PREVENTIVE MEDICINE. 2009;49(2-3):240-244Patja K; Hakala S; Prattala R; Ojala K; Boldo E; Oberg M
- Article: FOOD AND CHEMICAL TOXICOLOGY. 2008;46(11):3360-3367Bergkvist C; Oberg M; Appelgren M; Becker W; Aune M; Ankarberg EH; Berglund M; Hakansson H
- Article: TOXICOLOGICAL SCIENCES. 2005;85(2):935-943Öberg M; Bergander L; Håkansson H; Rannug U; Rannug A
- Article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2005;96(6):453-464Stern N; Korotkova M; Strandvik B; Oxlund H; Öberg M; Håkansson H; Lind PM
- Article: TOXICOLOGICAL SCIENCES. 2002;70(2):171-182Öberg M; Sjödin A; Casabona H; Nordgren I; Klasson-Wehler E; Håkansson H
- Article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2002;91(5):232-244Stern N; Öberg M; Casabona H; Trossvik C; Manzoor E; Johansson N; Lind M; Örberg J; Feinstein R; Johansson A; Chu I; Poon R; Yagminas A; Brouwer A; Jones B; Håkansson H
- Article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2002;91(5):220-231Öberg M; Stern N; Jensen S; Wesén C; Haglund P; Casabona H; Johansson N; Blomgren K; Håkansson H
- Visa fler
Alla övriga publikationer
- Letter: ENVIRONMENT INTERNATIONAL. 2024;192:109063Oberg M
- Meeting abstract: TOXICOLOGY LETTERS. 2022;368:S274-S275Brunken L; Silva AV; Oberg M
- Conference publication: TOXICOLOGY LETTERS. 2022;368:S277-S278Da Silva AV; Ringblom J; Moldeus P; Tornqvist E; Oberg M
- Conference publication: TOXICOLOGY LETTERS. 2021;350:S212Oberg M; Schenk L
- Conference publication: TOXICOLOGY LETTERS. 2021;350:S163Silva AV; Chu I; Feeley M; Bergman A; Hakansson H; Oberg M
- Conference publication: TOXICOLOGY LETTERS. 2021;350:S134-S135Svens K; Kenne K; Oberg M
- Corrigendum: ENVIRONMENTAL HEALTH PERSPECTIVES. 2020;128(8):89001Silva AV; Ringblom J; Lindh C; Scott K; Jakobsson K; Oberg M
- Review: ENVIRONMENTAL HEALTH PERSPECTIVES. 2020;128(7):76001Silva AV; Ringblom J; Lindh C; Scott K; Jakobsson K; Oberg M
- Letter: ENVIRONMENT INTERNATIONAL. 2020;134:105267Drakvik E; Altenburger R; Aoki Y; Backhaus T; Bahadori T; Barouki R; Brack W; Cronin MTD; Demeneix B; Bennekou SH; van Klaveren J; Kneuer C; Kolossa-Gehring M; Lebret E; Posthuma L; Reiber L; Rider C; Ruegg J; Testa G; van der Burg B; van der Voet H; Warhurst AM; van de Water B; Yamazaki K; Oberg M; Bergman A
- Conference publication: TOXICOLOGY LETTERS. 2018;295:S224Oberg M; Da Silva A; Ringblom J; Scott K; Lindh C; Jakobsson K
- Preprint: PEERJ PREPRINTS. 2018Backhaus T; Gustavsson M; Kortenkamp A; Rudén C; Scheringer M; Wendt-Rasch L; Ågerstrand M; Öberg M
- Preprint: PEERJ PREPRINTS. 2018Backhaus T; Gustavsson M; Kortenkamp A; Rudén C; Scheringer M; Wendt-Rasch L; Ågerstrand M; Öberg M
- Preprint: BIORXIV. 2017Birgersson L; Borbély G; Caporale N; Germain P-L; Leemans M; Rendel F; D’Agostino GA; Bressan RB; Cavallo F; Chorev NE; Kos VM; Lazzarin M; Pollard S; Sundström B; Tobon AL; Trattaro S; Zanella M; Bergman Å; Damdimopoulou P; Jönsson M; Kiess W; Kitraki E; Kiviranta H; Öberg M; Rantakkoko P; Rudén C; Söder O; Bornehag C-G; Demeneix B; Fini J-B; Gennings C; Nånberg E; Rüegg J; Sturve J; Testa G
- Review: CRITICAL REVIEWS IN TOXICOLOGY. 2016;46(3):241-260Johansson MKV; Johanson G; Oberg M
- Conference publication: TOXICOLOGY LETTERS. 2015;238(2):S267Johansson M; Gustafsson I; Johanson G; Oberg M
- Conference publication: TOXICOLOGY LETTERS. 2014;229:S123-S124Oberg M; Ringblom J; Johanson G
- Conference publication: TOXICOLOGY LETTERS. 2014;229:S46Oberg M; Tornqvist E; Annas A; Granath B; Jalkesten E; Cotgreave I
- Conference publication: TOXICOLOGY LETTERS. 2013;221:S228Oberg M; Ringblom J; Kalantari F; Johanson G
- Conference publication: TOXICOLOGY LETTERS. 2012;211:S125-S126Johansson M; Johanson G; Oberg M
- Conference publication: TOXICOLOGY LETTERS. 2012;211:S60Ringblom J; Johanson G; Oberg M
- Conference publication: TOXICOLOGY LETTERS. 2012;211:S173van Wendel de Joode B; Barraza D; Ruepert C; Maria Mora A; Cordoba L; Oberg M; Wesseling C; Mergler D; Lindh C
- Conference publication: 2011;:a4024Jaakkola MS; Oberg M; Woodward A; Peruga A; Pruss-Ustun A
- Meeting abstract: TOXICOLOGY LETTERS. 2008;180:S245Westerholm E; Oeberg M; Hakansson H
- Conference publication: EPIDEMIOLOGY. 2007;18(5):S58Boldo E; Oberg M; Medina S; Valero N; Patja K; Posada M
- Conference publication: EPIDEMIOLOGY. 2007;18(5):S58-S59Assessing health impact of environmental tobacco smoke (ETS) on asthma episodes in European childrenBoldo E; Medina S; Oberg M; Puklova V; Valero N; Posada M
- Meeting abstract: TOXICOLOGY LETTERS. 2006;164:S117Branting TJ; Ruden C; Oberg M; Bjorkdahl C
- Conference publication: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2004;197(3):216Öberg M; Bergander L; Häkansson H; Rannug U; Rannug A
- Published conference paper: ATLA-ALTERNATIVES TO LABORATORY ANIMALS. 2001;29(3):291-295Öberg M; Andersson PL; Johansson N; Tysklind M; Häkansson H
- Visa fler
Forskningsbidrag
- Swedish Research Council for Environment Agricultural Sciences and Spatial Planning1 May 2024 - 30 April 2026The project involves a popular science book and the organization of interdisciplinary seminars focusing on key issues in environmental medicine and society. The main emphasis is on persistent fluorinated environmental pollutants (PFAS). Primary target audiences, in addition to the general public, include stakeholders such as law, chemical engineering, history, and regulatory toxicology.The narrative has two main storylines:First, the historical connection from Nazi Germany and the U.S. atomic bomb to today´s global chemical industry and geopolitics. Companies were aware of the risks but used strategies to conceal them. The project investigates how science is employed to influence regulations.Second, the health of those affected, the challenges in "proving" harm, and risk communication. It examines issues of responsibility, including why it took society so long to take action. Researchers and their ties to the chemical industry are part of the narrative.The book forms a new genre - green crime - where the vulnerability of environmental science and the impact of the chemical industry on people´s health and trust are central themes. The ongoing Swedish legal case regarding contaminated drinking water in Ronneby provides dramatic opportunities to assess the collaboration between industry, authorities, and research. To engage stakeholders in the discussion, we will organize interdisciplinary seminars for target groups in related societal fields.
- Blood lipid profiling to explore effects of PFAS with relevance for cardiovascular disease in humansSwedish Research Council for Environment Agricultural Sciences and Spatial Planning1 January 2023 - 31 December 2025The estimated exposure and reported serum levels of PFAS, show that parts of the general population exceed the tolerable weekly intake and the highest exposure occur in areas with contaminated drinking water. One of the main human health concerns associated with PFAS exposure is perturbation of blood lipid homeostasis observed in epidemiological studies. Current risk assessments are hampered by a lack of understanding on the mode of action and the potential causal relationship with cardiovascular disease. In addition, combined effects of PFAS mixtures remain largely unknown. In this project we will elucidate the lipidomic profiles (lipidomics) in human blood samples representing populations with high and low levels of exposure. We will also use a prospective nested case-control study to identify lipid profiles associated with an increased risk of cardiovascular disease. Identified biomarkers from the epidemiological studies will be compared with results from experimental in vitro studies using human hepatocytes (HepaRG). This cell model will also be used to study the cellular regulation of lipids in relation to various PFAS and human relevant mixtures. By integration of the benchmark dose-response modelling approach, results from epidemiological and experimental studies will be transferable to a regulatory context and relevant for retrospective risk assessments as well as for prospective safety evaluations.
- Bank of Sweden Tercentenary Foundation1 January 2021 - 31 December 2023
- Bank of Sweden Tercentenary Foundation31 December 2020 - 30 December 2023
- Swedish Research Council for Environment Agricultural Sciences and Spatial Planning1 November 2019 - 31 May 2022
- Swedish Research Council for Environment Agricultural Sciences and Spatial Planning1 December 2018 - 30 November 2022
- Swedish Research Council for Environment Agricultural Sciences and Spatial Planning1 January 2018 - 31 December 2020
- Swedish Research Council for Environment Agricultural Sciences and Spatial Planning1 May 2017 - 30 April 2018
- Swedish Research Council for Environment Agricultural Sciences and Spatial Planning1 January 2017 - 31 December 2019
- Swedish Research Council for Environment Agricultural Sciences and Spatial Planning1 January 2017 - 31 December 2019
- Swedish Research Council1 January 2017 - 31 December 2019
- Swedish Research Council for Environment Agricultural Sciences and Spatial Planning1 January 2015 - 31 December 2017
- Swedish Research Council1 January 2013 - 31 December 2014
- Swedish Research Council1 January 2009 - 31 December 2011
Anställningar
- Lektor, Institutet för miljömedicin, Karolinska Institutet, 2025-
- Senior Forskare, Institutet för miljömedicin, Karolinska Institutet, 2022-2025
Examina och utbildning
- Docent, Toxikologi, Karolinska Institutet, 2012
- MEDICINE DOKTORSEXAMEN, Institutet för miljömedicin, Karolinska Institutet, 2003
